These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 10472551

  • 1. Effect of glucocorticoids, E. coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia.
    Mall V, Thomas KB, Sauter S, Niemeyer CM, Sutor AH.
    Klin Padiatr; 1999; 211(4):205-10. PubMed ID: 10472551
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
    Attarbaschi A, Mann G, Kronberger M, Witt V, Gadner H, Dworzak M.
    Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Changes in blood coagulation in treatment with ALL-BFM-90 and NHL-BFM-90 protocols].
    Sutor AH, Niemeyer C, Sauter S, Witt I, Kaufmehl K, Rombach A, Brandis M, Riehm H.
    Klin Padiatr; 1992; 204(4):264-73. PubMed ID: 1518263
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and drug monitoring of L-asparaginase treatment.
    Boos J.
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):96-8. PubMed ID: 9088996
    [Abstract] [Full Text] [Related]

  • 9. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
    Kwok CS, Kham SK, Ariffin H, Lin HP, Quah TC, Yeoh AE.
    Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
    [Abstract] [Full Text] [Related]

  • 10. Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol.
    Sutor AH, Mall V, Thomas KB.
    Klin Padiatr; 1999 Sep; 211(4):201-4. PubMed ID: 10472550
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Negligible hemostatic toxicity of intermediate-dose Erwinase in adult patients with acute lymphoblastic leukemia: preliminary data.
    Nocentini F, Gugliotta L, Catani L, Vianelli N, Baravelli S, Martelli V, Tura S.
    Haematologica; 1994 Sep; 79(6):546-9. PubMed ID: 7896215
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic drug monitoring of asparaginase in the ALL-BFM 2000 protocol between 2000 and 2007.
    Schrey D, Borghorst S, Lanvers-Kaminsky C, Hempel G, Gerss J, Möricke A, Schrappe M, Boos J.
    Pediatr Blood Cancer; 2010 Jul 01; 54(7):952-8. PubMed ID: 20108339
    [Abstract] [Full Text] [Related]

  • 14. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
    Ruud E, Holmstrøm H, de Lange C, Natvig S, Albertsen BK, Wesenberg F.
    Pediatr Hematol Oncol; 2006 Jul 01; 23(3):207-16. PubMed ID: 16517537
    [Abstract] [Full Text] [Related]

  • 15. Increased thrombin generation during fibrinogen and platelet recovery as an explanation for hypercoagulability in children with L-asparaginase therapy for ALL or NHL: a preliminary report.
    Korte W, Feldges A, Baumgartner C, Ullmann S, Niederer V, Schmid L.
    Klin Padiatr; 1994 Jul 01; 206(4):331-3. PubMed ID: 7967434
    [Abstract] [Full Text] [Related]

  • 16. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
    Appel IM, Hop WC, van Kessel-Bakvis C, Stigter R, Pieters R.
    Thromb Haemost; 2008 Aug 01; 100(2):330-7. PubMed ID: 18690355
    [Abstract] [Full Text] [Related]

  • 17. Hemostatic changes in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules.
    Miniero R, Pastore G, Saracco P, Messina M, Lange MM, Fiandino G, Iannacci L, Madon E.
    Am J Pediatr Hematol Oncol; 1986 Aug 01; 8(2):116-20. PubMed ID: 3461716
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Coagulation disorders during treatment with l-asparaginase preparations].
    Dobaczewski G.
    Wiad Lek; 1998 Aug 01; 51 Suppl 4():227-32. PubMed ID: 10731973
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.